Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Treating the Transparency Issue of Prescription Costs

Transparency is a word not often associated with the medical industry, particularly as it relates to the patient’s cost for medication. When prescribing drugs for their patients, providers typically do not have access to prescription pricing, nor to information on lower-cost options that may be more in line with a person’s out-of-pocket costs. With 24%…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Transparency is a word not often associated with the medical industry, particularly as it relates to the patient’s cost for medication. When prescribing drugs for their patients, providers typically do not have access to prescription pricing, nor to information on lower-cost options that may be more in line with a person’s out-of-pocket costs. With 24% percent of patients saying they’re not confident that they will be able to afford their medications, this lack of insight at the point-of-care can lead to distrust, affecting both the patient-physician relationship and the patient’s adherence to their treatment plan.

Transparency Means Trust

Most healthcare professionals do not have appropriate access to the data they need to manage drug spending. In fact, in a recent study of more than 500 healthcare professionals, 78% of respondents said they would like to have access to patient out-of-pocket costs. The data also showed that 69% of survey takers find it important to have access to information on low-cost therapeutic alternatives to prescriptions.

This urge for more transparency is a positive sign for provider-patient relationships. When a physician can explain all available options to a patient, there is a much higher likelihood that he or she will take an additional interest in their health overall. When a patient knows what they are paying for, the probability that they will stick with their medication plan increases. Trust will develop because of this clarity, instead of a feeling of deceit.

Better Relationships, Better Work

Automated processes are another way to convey information clearly to patients. This also has the additional benefit of improving clinic employee workflow. The 2018 AMA Prior Authorization Survey revealed that 65% of respondents wait at least one business day for prior authorization outcomes, with 26% waiting at least three business days.

These delays can lead to a direct abandonment of medication plans by patients, and without patient-specific information at the point-of-care, physicians are spending more time on non-clinical and administrative tasks rather than on patient care. This patient-specific data, however, can be placed on Electronic Health Record (EHR) systems, offering patients better price and prescription visibility while allowing physicians more time to focus on the detailed and specific needs of their patients.

EHR and eRx Need to Lead the Way

A trip to the doctor is already unnerving enough for most people; the looming threat of indefinite prescription pricing is another burden altogether. If providers of prescription pills and the pharmacies that sell them worked more in tandem to digitize and make pricing explicitly clear, they would both stand to gain. Further, patients would be more engaged with their treatment plans and stick to them, knowing that they are on the most suitable and affordable medications for their specific needs. Collaboration between EHR and eRx firms can help pave the path to price transparency, connecting pharmacies, physicians and patients together to improve the value of care and the reputation of the medical industry as a whole.

At ChartLogic, we are driven by the desire to improve patient care, office efficiency, and profitability for the physician practice. With that in mind, we will continue to add products and services that help practices improve efficiencies so that healthcare professionals can focus on what matters most: patient care.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512